ATOSSA THERAPEUTICS, INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
ATOSSA THERAPEUTICS, INC. (ATOS) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $0 for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2017-03-21
- ATOSSA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2016-03-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2015-12-31 was -$2.91M.
- ATOSSA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2015 was -$2.63M.
- ATOSSA THERAPEUTICS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2014 was -$2.09M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | -$2.91M derived: sum of 4 quarters · filed 2017-03-21 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $0.00 10-Q · filed 2016-08-12 | -$2.91M derived: sum of 3 quarters · filed 2017-03-21 | -$2.82M derived: sum of 4 quarters · filed 2017-03-21 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | -$2.91M derived: sum of 2 quarters · filed 2017-03-21 | -$2.82M derived: sum of 3 quarters · filed 2017-03-21 | -$2.14M derived: sum of 4 quarters · filed 2017-03-21 |
| 2015-12-31 | -$2.91M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | -$2.82M derived: sum of 2 quarters · filed 2017-03-21 | -$2.14M derived: sum of 3 quarters · filed 2017-03-21 | -$2.63M 10-K/A · filed 2017-03-21 |
| 2015-09-30 | $82.89K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | $765.35K derived: sum of 2 quarters · filed 2017-03-21 | $272.34K 10-Q/A · filed 2017-03-21 | |
| 2015-06-30 | $682.46K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-03-21 | $189.45K 10-Q/A · filed 2017-03-21 | ||
| 2015-03-31 | -$493.00K 10-Q/A · filed 2017-03-21 | |||
| 2014-12-31 | -$2.09M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |